Cell Death and Disease , 7 (7), e2312
doi: 10.1002/(SICI)1097-0231(19960331)10:5 3.0.CO;2-Q
Together, youll create a personalized plan that feels manageable and rooted in evidencewhether that includes bioidentical hormones, symptom-focused menopause care, or a program through our medical weight loss clinic featuring GLP-1 therapy for long-term metabolic support
While some studies did report positive results 9,10,11 many other studies reported negative results in improving brain function and memory 12,13,14
: , , As hopeful as this is, a few big questions remain, especially if we care about equity and not just headlines: - Will oral GLP-1s actually be covered by insurers and employers as long term therapy, instead of short weight loss sprints followed by predictable regain - How will pricing and step edits work when a patient has already been on an injectable for more than a year - Will these trials and future studies meaningfully include the diverse, underrepresented communities that carry a disproportionate burden of obesity, sleep apnea, and cardiometabolic disease : - Set expectations early: discuss obesity as chronic disease, and proactively plan for maintenance before stopping anything
